Erratum: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation (Oncotarget (2017) 8 (39087-39100) DOI: 10.18632/oncotarget.26197)

Inik Chang, Yozo Mitsui, Seul Ki Kim, Ji Su Sun, Hye Sook Jeon, Jung Yun Kang, Nam Ju Kang, Shinichiro Fukuhara, Ankurpreet Gill, Varahram Shahryari, Z. Laura Tabatabai, Kirsten L. Greene, Rajvir Dahiya, Dong Min Shin, Yuichiro Tanaka

Research output: Contribution to journalComment/debate

Abstract

This article has been corrected: The image for #4-3 in Figure 2C is incorrect. It is a duplicate image of panel #4-2. The corrected Figure 2C is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original languageEnglish
Number of pages1
JournalOncotarget
Volume9
Issue number75
DOIs
Publication statusPublished - 2018 Sep 1

All Science Journal Classification (ASJC) codes

  • Oncology

Fingerprint Dive into the research topics of 'Erratum: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation (Oncotarget (2017) 8 (39087-39100) DOI: 10.18632/oncotarget.26197)'. Together they form a unique fingerprint.

  • Cite this

    Chang, I., Mitsui, Y., Kim, S. K., Sun, J. S., Jeon, H. S., Kang, J. Y., Kang, N. J., Fukuhara, S., Gill, A., Shahryari, V., Laura Tabatabai, Z., Greene, K. L., Dahiya, R., Shin, D. M., & Tanaka, Y. (2018). Erratum: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation (Oncotarget (2017) 8 (39087-39100) DOI: 10.18632/oncotarget.26197). Oncotarget, 9(75). https://doi.org/10.18632/oncotarget.16598